How close are we to personalized pharmacotherapies and innovative technology for type 1 diabetes management?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How close are we to personalized pharmacotherapies and innovative technology for type 1 diabetes management?

Published:2023-08-03 Issue:15 Volume:24 Page:1661-1663
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Munir Kashif M.¹,Davis Stephen N.²

Affiliation:

1. Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Center for Diabetes and Endocrinology, Baltimore, Maryland, USA

2. Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2023.2241354

Reference13 articles.

1. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA1c in a Multiethnic Cohort of Adolescents and Young Adults With Type 1 Diabetes: The MILLENNIALS Study

2. Closed-loop insulin delivery: update on the state of the field and emerging technologies

3. Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes

4. Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study

5. Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP